Prime Medicine, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1288518,
    "name": "Prime Medicine, Inc.",
    "stock_name": "Prime Medicine, Inc.",
    "full_name": "Prime Medicine, Inc.",
    "name_url": "stocks-analysis/prime-medicine-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "3.85",
    "chg": 0.55,
    "chgp": "16.67%",
    "dir": 1,
    "prev_price": "3.30",
    "mcapval": "693.18",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US74168J1016",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "12.44 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prime-medicine-inc-1288518-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Prime Medicine Stock Hits Day Low of $4.45 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-stock-hits-day-low-of-445-amid-price-pressure-3671596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrimeMedicineIn_priceRelatedfactors_3671596.png",
        "date": "2025-11-04 18:37:23",
        "description": "Prime Medicine, Inc. has faced a significant stock decline, with a notable drop in both weekly and monthly performance. Despite reporting substantial growth in net sales, the company struggles with negative EBITDA and high operating cash flow losses. Its long-term performance reflects considerable volatility in the market."
      },
      {
        "title": "Prime Medicine, Inc. Experiences Evaluation Revision Amidst Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-inc-technical-trend-changes-from-bullish-to-mildly-bullish-amid-price-fluctuations-3620028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrimeMedicineIn_technicaldot_3620028.png",
        "date": "2025-10-14 16:31:07",
        "description": "Prime Medicine, Inc., a small-cap pharmaceutical company, has recently adjusted its evaluation amid market dynamics. The stock is currently priced at $5.65, with a notable annual return of 55.22%. Technical indicators show a mixed outlook, reflecting the company's volatility and resilience in a competitive sector."
      },
      {
        "title": "Is Prime Medicine, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prime-medicine-inc-technically-bullish-or-bearish-3617763",
        "imagepath": "",
        "date": "2025-10-14 11:40:26",
        "description": "As of 10 October 2025, the technical trend for Prime Medicine, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the RSI readings are bearish for both weekly and monthly periods. The Bollinger Bands indicate a mildly bullish stance weekly and bullish monthly. Moving averages are bullish on a daily basis, while the Dow Theory shows a mildly bullish trend in both weekly and monthly time frames. The OBV is mildly bullish weekly but mildly bearish monthly. \n\nIn terms of performance, the stock has returned 38.82% over the past month compared to a mere 0.31% for the S&P 500, and it has a year-to-date return of 93.49% against the S&P 500's 11.41%. Overall, the current technical stance is mildly bullish, driven by the mixed indicators across different time frames...."
      },
      {
        "title": "Is Prime Medicine, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prime-medicine-inc-technically-bullish-or-bearish-3614756",
        "imagepath": "",
        "date": "2025-10-13 11:42:15",
        "description": "As of 10 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish daily moving average and a bullish monthly Bollinger Band. However, the weekly MACD is bullish while the RSI readings are bearish for both weekly and monthly periods, indicating some weakness. The Dow Theory supports a mildly bullish outlook on both weekly and monthly time frames. Overall, while there are some positive indicators, the bearish RSI and KST suggest caution. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Prime Medicine, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prime-medicine-inc-technically-bullish-or-bearish-3613090",
        "imagepath": "",
        "date": "2025-10-12 11:29:20",
        "description": "As of 10 October 2025, the technical trend for Prime Medicine, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the RSI readings are bearish for both weekly and monthly periods, indicating some weakness. The Bollinger Bands show a mildly bullish stance weekly and bullish monthly, while moving averages are bullish on a daily basis. Dow Theory supports a mildly bullish outlook on both weekly and monthly time frames. The overall stance is mildly bullish, driven primarily by the moving averages and Bollinger Bands, despite bearish RSI and KST indicators.\n\nIn terms of performance, the stock has returned 46.02% over the past month compared to a mere 0.31% for the S&P 500, and it has a year-to-date return of 94.52% versus 11.41% for the benchmark...."
      },
      {
        "title": "Prime Medicine Soars 9.88% to Day High of $6.85 Amid Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-soars-988-to-day-high-of-685-amid-strong-intraday-performance-3608181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrimeMedicineIn_priceRelatedfactors_3608181.png",
        "date": "2025-10-09 21:05:38",
        "description": "Prime Medicine, Inc. has experienced notable stock performance, with significant gains over various timeframes, including a year-to-date return of 120.89%. Despite challenges such as negative EBITDA and a substantial net loss, the company reported a remarkable increase in net sales, attracting considerable institutional interest."
      },
      {
        "title": "Prime Medicine, Inc. Hits New 52-Week High of $6.94",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-inc-hits-new-52-week-high-of-694-3601704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrimeMedicineIn_priceRelatedfactors_3601704.png",
        "date": "2025-10-07 22:02:51",
        "description": "Prime Medicine, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. With a market capitalization of USD 693 million, the company faces challenges, including a negative return on equity and a lack of dividend yield, as it navigates the competitive biotechnology sector."
      },
      {
        "title": "Prime Medicine, Inc. Hits New 52-Week High of $6.92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-inc-hits-new-52-week-high-of-692-3595687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrimeMedicineIn_priceRelatedfactors_3595687.png",
        "date": "2025-10-06 17:43:35",
        "description": "Prime Medicine, Inc. has achieved a new 52-week high, recovering significantly from its previous low. However, its one-year performance remains negative, contrasting with broader market gains. The company faces financial challenges, including a negative return on equity and high price-to-book ratio, while lacking a dividend."
      },
      {
        "title": "Prime Medicine, Inc. Hits New 52-Week High of $5.82",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prime-medicine-inc-hits-new-52-week-high-of-582-3588419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrimeMedicineIn_priceRelatedfactors_3588419.png",
        "date": "2025-10-02 22:42:15",
        "description": "Prime Medicine, Inc. has achieved a new 52-week high, reflecting a significant recovery from its previous low. However, the company's one-year performance shows a decline, contrasting with broader market gains. Operating in a challenging environment, it faces negative returns and high valuation metrics, while not offering dividends."
      }
    ],
    "total": 18,
    "sid": "1288518",
    "stock_news_url": "https://www.marketsmojo.com/news/prime-medicine-inc-1288518"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Prime Medicine Stock Hits Day Low of $4.45 Amid Price Pressure

2025-11-04 18:37:23

Prime Medicine, Inc. has faced a significant stock decline, with a notable drop in both weekly and monthly performance. Despite reporting substantial growth in net sales, the company struggles with negative EBITDA and high operating cash flow losses. Its long-term performance reflects considerable volatility in the market.

Prime Medicine, Inc. Experiences Evaluation Revision Amidst Strong Market Performance

2025-10-14 16:31:07

Prime Medicine, Inc., a small-cap pharmaceutical company, has recently adjusted its evaluation amid market dynamics. The stock is currently priced at $5.65, with a notable annual return of 55.22%. Technical indicators show a mixed outlook, reflecting the company's volatility and resilience in a competitive sector.

Is Prime Medicine, Inc. technically bullish or bearish?

2025-10-14 11:40:26

As of 10 October 2025, the technical trend for Prime Medicine, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the RSI readings are bearish for both weekly and monthly periods. The Bollinger Bands indicate a mildly bullish stance weekly and bullish monthly. Moving averages are bullish on a daily basis, while the Dow Theory shows a mildly bullish trend in both weekly and monthly time frames. The OBV is mildly bullish weekly but mildly bearish monthly. In terms of performance, the stock has returned 38.82% over the past month compared to a mere 0.31% for the S&P 500, and it has a year-to-date return of 93.49% against the S&P 500's 11.41%. Overall, the current technical stance is mildly bullish, driven by the mixed indicators across different time frames....

Is Prime Medicine, Inc. technically bullish or bearish?

2025-10-13 11:42:15

As of 10 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish daily moving average and a bullish monthly Bollinger Band. However, the weekly MACD is bullish while the RSI readings are bearish for both weekly and monthly periods, indicating some weakness. The Dow Theory supports a mildly bullish outlook on both weekly and monthly time frames. Overall, while there are some positive indicators, the bearish RSI and KST suggest caution. Multi-period return data is not available for comparison with the S&P 500....

Is Prime Medicine, Inc. technically bullish or bearish?

2025-10-12 11:29:20

As of 10 October 2025, the technical trend for Prime Medicine, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the RSI readings are bearish for both weekly and monthly periods, indicating some weakness. The Bollinger Bands show a mildly bullish stance weekly and bullish monthly, while moving averages are bullish on a daily basis. Dow Theory supports a mildly bullish outlook on both weekly and monthly time frames. The overall stance is mildly bullish, driven primarily by the moving averages and Bollinger Bands, despite bearish RSI and KST indicators. In terms of performance, the stock has returned 46.02% over the past month compared to a mere 0.31% for the S&P 500, and it has a year-to-date return of 94.52% versus 11.41% for the benchmark....

Prime Medicine Soars 9.88% to Day High of $6.85 Amid Strong Intraday Performance

2025-10-09 21:05:38

Prime Medicine, Inc. has experienced notable stock performance, with significant gains over various timeframes, including a year-to-date return of 120.89%. Despite challenges such as negative EBITDA and a substantial net loss, the company reported a remarkable increase in net sales, attracting considerable institutional interest.

Prime Medicine, Inc. Hits New 52-Week High of $6.94

2025-10-07 22:02:51

Prime Medicine, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. With a market capitalization of USD 693 million, the company faces challenges, including a negative return on equity and a lack of dividend yield, as it navigates the competitive biotechnology sector.

Prime Medicine, Inc. Hits New 52-Week High of $6.92

2025-10-06 17:43:35

Prime Medicine, Inc. has achieved a new 52-week high, recovering significantly from its previous low. However, its one-year performance remains negative, contrasting with broader market gains. The company faces financial challenges, including a negative return on equity and high price-to-book ratio, while lacking a dividend.

Prime Medicine, Inc. Hits New 52-Week High of $5.82

2025-10-02 22:42:15

Prime Medicine, Inc. has achieved a new 52-week high, reflecting a significant recovery from its previous low. However, the company's one-year performance shows a decline, contrasting with broader market gains. Operating in a challenging environment, it faces negative returns and high valuation metrics, while not offering dividends.

View All News